RBC Capital Mkts has recently initiated OmniAb Inc (OABI) stock to Outperform rating, as announced on November 29, 2023, according to Finviz. Earlier, on April 21, 2023, The Benchmark Company had initiated the stock to Buy, setting a price target of $8. Craig Hallum also initiated Buy rating with a price target of $10. Additionally, Cowen initiated Outperform rating on February 22, 2023, with a target price of $10. H.C. Wainwright analysts, in their report published on February 13, 2023, also initiated Buy rating and set a price target of $11 for OmniAb Inc’s stock. Analyst ratings are significant because they provide insights into stock performance expectations, influencing investor decisions and market sentiment.
Sponsored
OmniAb Inc (OABI) Stock Trading Recap
On Wednesday, OmniAb Inc (OABI) stock saw a modest uptick, ending the day at $3.99 which represents a slight increase of $0.05 or 1.27% from the prior close of $3.94. The stock opened at $3.93 and touched a low of $3.86 during the day, reaching a high of $4.09. The volume of shares traded was 0.94 million exceeding the average volume of 0.38 million.
OABI Stock Performance and Moving Averages
In recent trading, OmniAb Inc (OABI) stock price has shown some volatility, fluctuating 1.27% over the last five trades and -4.09% over the past 30 trades. This represents a notable shift from earlier in the year. Over the last six months, the stock has risen by -12.50%, and it has plunged by -10.94% in the previous three months. Currently, OABI is trading at 0.85%, -3.88%, and -14.99% relative to its 20-Day, 50-Day, and 200-Day Simple Moving Averages, respectively.
As of the latest trading close, OABI, a Healthcare sector stock, is trading -40.58% below its 52-week high but remains 12.08% above its 52-week low. The Average True Range (ATR) (14 days) of 0.14 highlights the stock’s average volatility, providing insight into how much the price typically fluctuates. This measure is crucial for understanding potential price swings and assessing overall market risk.
OmniAb Inc’s Profitability and Valuation Ratios
OmniAb Inc’s profitability metrics reveal strong financial health. The company currently boasts an operating margin of -381.54% and a profit margin of -287.29%, with a gross margin of -12.50%. The profit margin, also known as the revenue ratio or gross profit ratio, measures how efficiently a company converts sales into net income; higher margins indicate greater profitability.
In terms of valuation, OmniAb Inc’s market capitalization stands at $471.47 million. Market cap represents the total value of all outstanding shares and is a key indicator of a company’s market value. Additionally, the Price-to-Sales Ratio is 21.72, reflecting the market’s valuation of the company’s sales, while the Price-to-Book Ratio is 1.6, comparing the market value to the company’s book value.
Understanding Insider Trading
Investors often prefer to invest in shares held by company insiders, as management is typically more aligned with the company’s success and shareholder interests. Currently, insiders own just 19.43% of OmniAb Inc (OABI)’s shares, while financial institutions hold 54.91%.